• Ixekizumab-treatment-emergent photosensitive cutaneous eruption 

  Anthony, E; Bala, HR; Goh, MSY; Balta, S; Foley, P (WILEY, 2018-11-01)

• Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENT. 

  Simonis, FD; Barbas, CSV; Artigas-Raventós, A; Canet, J; Determann, RM; Anstey, J; Hedenstierna, G; Hemmes, SNT; Hermans, G; Hiesmayr, M; ... (Springer Science and Business Media LLC, 2018-03-21)

  BACKGROUND: The majority of critically ill patients do not suffer from acute respiratory distress syndrome (ARDS). To improve the treatment of these patients, we aimed to identify potentially modifiable factors associated ...

• ASXL1 c.1934dup;p.Gly646Trpfs*12-a true somatic alteration requiring a new approach 

  Yannakou, CK; Jones, K; McBean, M; Thompson, ER; Ryland, GL; Doig, K; Markham, J; Westerman, D; Blombery, P (NATURE PUBLISHING GROUP, 2017-12-20)

View more